Cases reported "Vaccinia"

Filter by keywords:



Filtering documents. Please wait...

1/4. smallpox vaccine adverse events among civilians--united states, February 25-March 3, 2003.

    During the civilian smallpox vaccination program, CDC, the food and Drug Administration, and state health departments are conducting surveillance for vaccine-associated adverse events. In the first stage of the program, active surveillance is being conducted for potentially life-threatening, moderate-to-severe, and other serious adverse events and for vaccinia transmission to contacts of vaccinees (Table). Nonserious events are reported through passive surveillance and are expected to be underreported. This report summarizes smallpox vaccine adverse events reported among civilians vaccinated as of February 28, 2003, and among contacts of vaccinees, received by CDC from the Vaccine Adverse Event Reporting System (VAERS) as of March 3.
- - - - - - - - - -
ranking = 1
keywords = transmission
(Clic here for more details about this article)

2/4. Tertiary contact vaccinia in a breastfeeding infant.

    On May 4, 2003, a US Army soldier received primary smallpox vaccination and experienced a primary uptake reaction at the inoculation site on days 6 through 8. The vaccinee reported observing all of the standard precautions to avoid household spread. In mid May, his breastfeeding wife developed vesicles on both areolas. On May 29, their infant daughter developed a papule on her philtrum. Contact vaccinia was confirmed by positive polymerase chain reaction and culture for vaccinia of both the maternal and infant lesions. This is the first documented case of inadvertent contact vaccinia transmission from a mother to her infant through direct skin-to-skin and skin-to-mucous membrane contact while breastfeeding. The mechanism of transfer from the vaccinee to the spouse is uncertain. This report demonstrates that breastfeeding infants living in close contact with smallpox vaccinees are at potential risk for contact vaccinia, even if the vaccinee is not the breastfeeding mother, and highlights the need for special precautions to prevent secondary transfer to breastfeeding mothers.
- - - - - - - - - -
ranking = 1
keywords = transmission
(Clic here for more details about this article)

3/4. Secondary and tertiary transfer of vaccinia virus among U.S. military personnel--united states and worldwide, 2002-2004.

    In December 2002, the Department of Defense (DoD) began vaccinating military personnel as part of the pre-event vaccination program. Because vaccinia virus is present on the skin at the site of vaccination, it can spread to other parts of the body (i.e., autoinoculation) or to contacts of vaccinees (i.e., contact transfer). To prevent autoinoculation and contact transfer, DoD gave vaccinees printed information that focused on hand washing, covering the vaccination site, and limiting contact with infants (1,2). This report describes cases of contact transfer of vaccinia virus among vaccinated military personnel since December 2002; findings indicate that contact transfer of vaccinia virus is rare. Continued efforts are needed to educate vaccinees about the importance of proper vaccination-site care in preventing contact transmission, especially in household settings.
- - - - - - - - - -
ranking = 1
keywords = transmission
(Clic here for more details about this article)

4/4. Laboratory-confirmed transmission of vaccinia virus infection through sexual contact with a military vaccinee.

    A laboratory-confirmed, inadvertent transmission of vaccinia virus from an unusual source highlights the importance of epidemiologic tracing, proper biosafety practices in the clinical diagnostic laboratories, and educating clinicians and laboratorians to potential bioterrorism-initiated outbreaks as well as look-alike disease discrimination.
- - - - - - - - - -
ranking = 5
keywords = transmission
(Clic here for more details about this article)


Leave a message about 'Vaccinia'


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.